Home > Food & Beverages > Nutraceuticals > Vitamins > Glucosinolates Market
Glucosinolates market from the broccoli extract segment is anticipated to record more than 6.2% CAGR from 2023 to 2032. Broccoli is rich in glucosinolates that help fight and suppress diseases like cancer. It is also a good source of vitamins like A, B, C, and K and contains antioxidants. The need for affordable functional foods that enable disease prevention could drive the demand for broccoli extract supplements. A fast-paced urban lifestyle would trigger the need for plant-based drugs in tablet form compared to actual foods. Growing awareness regarding the benefits of broccoli extracts will encourage product sales over the forecast period.
Glucosinolates market from the mustard seed extract segment is expected to cross USD 60 million by 2032. The use of mustard seed glucosinolates is growing in the pharmaceutical sector as it works as a suitable ingredient for ointments, compresses, plasters, and liniments. They are also excellent for detoxifying chronic illnesses and treating bronchial infections. The growing elderly population that is prone to diseases and infections would drive the demand for new medicines as well as fuel pharmaceutical R&D and drug development activities that involve the use of mustard seed extracts.
Asia Pacific glucosinolates market share is projected to cross USD 130 million by 2032 owing to the rising demand for insecticides and pesticides in the region. China has become one of the largest pesticide users in the globe with 43% of the global consumption. Efforts to avoid agriculture adulteration will fuel the demand for glucosinolates in the region. The rising prevalence of liver, heart, and lung diseases and the consumer demand for organic drugs and treatments will support market size.